Physician

Shalu Singh, M.D.

According to 2025 Medicare claims, Shalu Singh, M.D. (NPI: 1245228998) practices neurology in the Weirton-Steubenville, WV-OH market, with the plurality of this provider's patient population coming from Jefferson, OH. This provider's primary affiliated billing organization is TRINITY WEST (NPI: 1043234677; TIN: 34-0875691) and primary practice location at 43952-1380. Singh is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 756 traditional Medicare patients, billed 1,885 HCPCS/CPT codes, and received $137,819 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 7,906 prescription claims across 1,007 beneficiaries totaling $1,604,681 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). 2022 DME data shows 12 claims. Open Payments data shows 7 records totaling $109. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $260,690 to $137,819. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,224,842 and ending at $1,604,681. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $737 to $505.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,165	3,504	$260,690
2016	1,031	3,048	$221,946
2017	1,027	2,996	$206,787
2018	991	2,820	$210,077
2019	1,030	2,938	$214,086
2020	876	2,363	$155,493
2021	858	2,218	$159,371
2022	796	1,957	$136,611
2023	811	1,988	$138,489
2024	756	1,885	$137,819

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	743	6,026	$1,224,842
2016	665	5,571	$1,058,958
2017	746	6,554	$1,534,222
2018	835	8,036	$1,704,538
2019	904	9,344	$1,679,586
2020	914	9,390	$1,550,428
2021	936	8,367	$1,581,746
2022	952	7,566	$1,212,763
2023	979	7,687	$1,252,287
2024	1,007	7,906	$1,604,681

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	14	$632
2017	N/R	32	$1,032
2018	N/R	14	$114
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$113
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	98	106	$113
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	105	105	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	292	428	$82
99442	Telephone medical discussion with physician, 11-20 minutes	67	75	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	422	589	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nurtec Odt	Rimegepant Sulfate	99	2,735	$150,181
Tecfidera	Dimethyl Fumarate	16	480	$148,750
Avonex (4 Pack)	Interferon Beta-1a	17	476	$139,663
Vumerity	Diroximel Fumarate	13	390	$129,670
Rebif	Interferon Beta-1a/Albumin	12	336	$119,595

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$109	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shalu Singh, M.D.?

Tedicare shows public-source Medicare data for Shalu Singh, M.D. (NPI 1245228998), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shalu Singh, M.D. have ACO affiliation data?

Shalu Singh, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Shalu Singh, M.D.?

Shalu Singh, M.D. is linked to TRINITY WEST (billing NPI 1043234677) in the available physician profile data.

Does Shalu Singh, M.D. have Open Payments data?

Shalu Singh, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.